Sort by
Refine Your Search
-
Are you an ambitious scientist looking for your next challenge? Do you have a PhD (or near to completion) in a quantitative subject, an interest in Polar research and the skills to develop our Earth
-
the boundaries of 6G technology. Your primary responsibility will be to spearhead research initiatives aimed at developing the domain of Edge Computing for 6G Networks. Holding a PhD (or have submitted your thesis
-
torsion apparatus under controlled conditions, and build new models of stress corrosion cracking under diagenetic conditions, quantified by the other team member. You will have a PhD in Geology or
-
experiments by the other team member. You will have a PhD in Geology or Geophysics, and have experience in geological field work in deformed rocks, sedimentary petrography and geochemistry, quantitative
-
them in the laboratory. You will also be responsible for analysing the data and dissemination of the results in a range of written formats and orally at farm events, workshops and conferences. You will
-
Lancaster. You will be expected to produce peer-reviewed papers documenting the results. You will have, or be close to obtaining, a PhD in the field of Atmospheric or Climate Science, or a related discipline
-
large team with colleagues in Leeds studying other aspects of blood clot structure and function and their influence on thrombosis. You will have a PhD in molecular biology, cell biology, biomedical
-
researchers who have been in receipt of EPSRC funding (fees and/or maintenance) during their PhD. To be eligible for this year’s scheme candidates must have a PhD (awarded after October 2024) or have sat
-
their ability to enable cell adhesion and proliferation and differentiation. The objective of this work is to generate preliminary data that will reinforce and create a strong foundation for a grant proposal to
-
are also open to discussing flexible working arrangements. Are you an ambitious and talented statistician with expertise in individual participant data meta-analysis (IPDMA) of clinical trials and